Research Paper Volume 14, Issue 9 pp 4014—4035
Prognostic value and immune characteristics of RUNX gene family in human cancers: a pan-cancer analysis
Figure 11. Drug sensitivity analysis of RUNX gene family gene. RUNX1 expression was positively associated with sensitivity to (A) batracylin, (B) triciribine phosphate, (C) nelarabine, (D) chelerythrine, (E) irinotecan, (F) bendamustine, (G) clofarabine, and (H) asparaginase; RUNX2 expression was positively related to sensitivity to (I) staurosporine, (J) bleomycin, and (K) dasatinib; and RUNX3 expression was positively associated with sensitivity to (L) hypothemycin, (M) selumetinib, (N) PD-98059, and (O) dabrafenib and negatively related to sensitivity to (P) dasatinib.